NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Retatrutide from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply
+4 more ↓
76%
Finnrick rating
#229 of 378 Retatrutide vendors
12 of 16 classifiable tests passed
customers 4.5★ (23)
methodology · Purity focus
Finnrick analysis · Retatrutide

Tianjin Eleli's Retatrutide profile is pulled down by two 0% purity/0 mg identity failures, including one in June after a cleaner run. Most other vials clear purity and fill, so batch/label clustering matters.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Eleli Technology Development

Source code, product-origin fields and a hidden mail target point beyond the Tianjin storefront to a second operator. The report traces the claimed address, young domain, offshore contact rails, dead Discord invites and unsupported FDA/warehouse claims.

21 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutideselected
$0.87
76%
16
2
GHK-Cu
$0.07
73%
6
3
Tirzepatide
$0.38
63%
7
4
BPC-157
$0.75
53%
6
5
Cagrilintide
$2.16
52%
1
6
Tesamorelin
$1.81
47%
4
7
TB-500
$1.65
36%
3
8
GLOW
-
-
0
9
Ipamorelin
$1.24
-
0
10
Melanotan II
$0.45
-
0
11
NAD+
$0.01
-
0
12
PT-141
$0.56
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%26 Jan 2026: 78%4 Feb 2026: 74%10 Feb 2026: 75%3 Mar 2026: 72%3 Mar 2026: 73%25 Mar 2026: 75%28 Apr 2026: 77%8 May 2026: 78%6 Jun 2026: 79%15 Jun 2026: 80%15 Jun 2026: 76%24 Jun 2026: 77%26 Jun 2026: 73%26 Jun 2026: 75%13 Jul 2026: 75%9 Aug 2026: 76%29 Sep 2026: current 76%78%77%76%Jan 26Sep 26
Showing Retatrutide tests only
Free peptide testing

Ordered Retatrutide from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply
Tianjin Eleli Technology Development Retatrutide test history
COA-backed lab tests
1-10 of 16

About Tianjin Eleli Technology Development test results from Finnrick

Tianjin Eleli Technology Development is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Eleli Technology Development peptides in this dataset are BPC-157 (6 tests), Cagrilintide (1 test) and GHK-Cu (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Retatrutide from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply